Glowside was the lead financial advisor of Recipharm on the carve out and sale of Medicamenta and Davi for approximately Eur 31 M.
/ Artigo
Glowside was the lead financial advisor of Recipharm on the carve out and sale of Medicamenta and Davi for approximately Eur 31 M.
/ Outras Publicações
Boardroom Advisory
Restructuring & Transformation
Business Planning & Valuation
M&A (Mergers & Acquisitions)
Debt Advisory
